All Posts
PT-141 Peptide for Men: Desire vs. Performance
PT-141 targets desire in the male brain via melanocortin receptors. See how it differs from ED meds.
How Summer Heat May Accelerate Biological Aging
For most of us, summer is the season we look forward to most: more sunlight, time outside, movement, social connection. These are all important longevity…
What Is PT-141? Low Libido Peptide Guide
PT-141 works on the brain, not blood flow, to target sexual desire at its source. See how this peptide may help.
Canagliflozin as a Longevity Therapy: AgelessRx Trial Findings
A closer look at our Canagliflozin pilot trial, including the study design, metabolic findings, glucose response, and tolerability in healthy adults.
Low Dose Naltrexone for Healthspan: What Our Real-World Study Found
Explore how Low Dose Naltrexone may target inflammaging and support healthspan, based on real-world findings from 5,500 participants.
Does NAD+ Decline With Age? What a New Blood Study Really Shows
If you follow longevity science, you’ve seen this pattern before. A new study drops, a headline flattens it into one bold claim, and the claim…
AgelessRx PEARL Trial: Rapamycin & LDN Bone Density Findings
Explore PEARL trial findings on Rapamycin, Low Dose Naltrexone, and bone density, including a notable case report, potential mechanisms, safety considerations, and the need for…
What The AgelessRx Rapamycin Study Revealed About Bioavailability
Fat intake, gut microbiome composition, and enzyme activity may all influence Rapamycin absorption. See what our study revealed.
Understanding Our SF-36 Quality of Life Study
Curious about the SF-36 quality of life study? Discover what this validated health survey measures and what our longevity research found.
LDN and NAD+ for Long COVID Fatigue: AgelessRx Trial Findings
Low Dose Naltrexone and NAD+ were tested together for Long COVID fatigue in our trial. Learn what the results showed and why the combination worked.
Acarbose Longevity Research: AgelessRx Trial Data
Our Research Team tracked Acarbose as a longevity intervention in a pilot trial. See biomarker findings, glucose data, and tolerability results.
Microdosing GLP-1 for Longevity: What Our Trial Is Studying
Explore how Microdosing Semaglutide may support metabolic health, inflammation, and longevity, including what our GLP-1 trial is studying.